Page 66 - ARNM-3-2

Advances in Radiotherapy
& Nuclear Medicine 18 F-FDG uptake and hypercholesterolemia

Rep. 2024;14(1):24255. doi: 10.1016/j.atherosclerosis.2018.08.010
doi: 10.1038/s41598-024-75375-4 16. Al-Enezi MS. Assessment of the correlation between arterial
lumen density and its metabolic activity in atherosclerotic
5. Moran AE, Forouzanfar MH, Roth GA, et al. Temporal 18
trends in ischemic heart disease mortality in 21 world patients using F-FDG positron emission tomography/
regions, 1980 to 2010: The Global Burden of Disease 2010 computed tomography. Am J Nucl Med Mol Imaging.
study. Circulation. 2014;129(14):1483-1492. 2023;13(1):18-25.
doi: 10.1161/CIRCULATIONAHA.113.004042 17. Blomberg BA, de Jong PA, Thomassen A, et al. Thoracic
aorta calcification but not inflammation is associated
6. Fleg JL, Forman DE, Berra K, et al. Secondary prevention with increased cardiovascular disease risk: Results of
of atherosclerotic cardiovascular disease in older adults: the CAMONA study. Eur J Nucl Med Mol Imaging.
A scientific statement from the American Heart Association. 2017;44(2):249-258.
Circulation. 2013;128(22):2422-2446.
doi: 10.1007/s00259-016-3552-9
doi: 10.1161/01.cir.0000436752.99896.22
18. Al-Enezi MS, Bentourkia M. PET-18F-FDG
7. Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Pharmacokinetic Modeling Without Blood Sampling in
Nasri H. Atherosclerosis: Process, indicators, risk factors Arteries with Atherosclerosis. In: 2020 IEEE Nuclear Science
and new hopes. Int J Prev Med. 2014;5(8):927-946. Symposium and Medical Imaging Conference (NSS/MIC).
8. Viedma-Guiard E., Guidoux C, Amarenco P, Meseguer E. Boston, MA, USA: IEEE, 2020. p1-3.
Aortic Sources of Embolism. Front Neurol. 2021;11:606663. doi: 10.1109/NSS/MIC42677.2020.9507855
doi: 10.3389/fneur.2020.606663 19. Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of
9. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of coronary artery plaque and risk of incident cardiovascular
plaque formation and rupture. Circ Res. 2014;114(12):1852- events. JAMA. 2014;311(3):271-278.
1866. doi: 10.1001/jama.2013.282535

doi: 10.1161/CIRCRESAHA.114.302721 20. Razavi AC, Whelton SP, Blumenthal RS, Blaha MJ, Dzaye O.
10. Fan J, Watanabe T. Atherosclerosis: Known and unknown. Beyond the Agatston calcium score: Role of calcium density
Pathol Int. 2022;72(3):151-160. and other calcified plaque markers for cardiovascular
disease prediction. Curr Opin Cardiol. 2025;40(1):56-62.
doi: 10.1111/pin.13202
doi: 10.1097/HCO.0000000000001185
11. Prasad K, Mishra M. Mechanism of hypercholesterolemia-
induced atherosclerosis. Rev Cardiovasc Med. 2022;23(6):212. 21. Lairez O, Hyafil F. A clinical role of PET in atherosclerosis and
vulnerable plaques? Semin Nucl Med. 2020;50(4):311-318.
doi: 10.31083/j.rcm2306212
doi: 10.1053/j.semnuclmed.2020.02.017
12. Jansen ACM, van Aalst-Cohen ES, Tanck MW, et al. The
contribution of classical risk factors to cardiovascular disease 22. Al-Enezi MS. Arterial tissue-to-psoas muscle ratio:
in familial hypercholesterolaemia: Data in 2400 patients. A novel metric for quantifying fluorodeoxyglucose uptake
J Intern Med. 2004;256(6):482-490. in predicting the association between atherosclerotic
inflammation and arterial calcification. Eurasian J Med
doi: 10.1111/j.1365-2796.2004.01405.x Oncol. 2025;9(1):214-222.
13. Schmidt HH, Hill S, Makariou EV, Feuerstein IM, doi: 10.36922/ejmo.7727
Dugi KA, Hoeg JM. Relation of cholesterol-year score to
severity of calcific atherosclerosis and tissue deposition in 23. Okamura Y, Nakanishi R, Hashimoto H, Mizumura S,
homozygous familial hypercholesterolemia. Am J Cardiol. Homma S, Ikeda T. Relationship Between
1996;77(8):575-580. 18 F-fluorodeoxyglucose uptake on positron emission
tomography and aortic calcification. Ann Nucl Cardiol.
doi: 10.1016/s0002-9149(97)89309-5
2022;8(1):57-66.
14. Pérez de Isla L, Alonso R, Mata N, et al. Predicting doi: 10.17996/anc.22-00160
cardiovascular events in familial hypercholesterolemia: The
SAFEHEART registry (Spanish familial hypercholesterolemia 24. Høilund-Carlsen PF, Piri R, Madsen PL, et al. Atherosclerosis
cohort study). Circulation. 2017;135:2133-2144. burdens in diabetes mellitus: Assessment by PET imaging.
Int J Mol Sci. 2022;23(18):10268.
doi: 10.1161/CIRCULATIONAHA.116.024541
doi: 10.3390/ijms231810268
15. Béliard S, Boccara F, Cariou B, et al. High burden of
recurrent cardiovascular events in heterozygous familial 25. Bucerius J, Hyafil F, Verberne HJ, et al. Position paper of the
hypercholesterolemia: The French familial hypercholesterolemia cardiovascular committee of the European Association of
registry. Atherosclerosis. 2018;277:334-340. Nuclear Medicine (EANM) on PET imaging of atherosclerosis.

Volume 3 Issue 2 (2025) 58 doi: 10.36922/arnm.8540